Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 12, 2024 (Week 41)
Reporting Area Gonorrhea §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 4,648 12,302 382,482 477,735
New England 174 450 9,038 13,151
Connecticut - 96 179 3,339
Maine - 25 401 462
Massachusetts 149 230 6,960 7,633
New Hampshire 2 23 406 465
Rhode Island 23 212 967 1,070
Vermont - 8 125 182
Middle Atlantic 956 1,642 56,090 58,963
New Jersey - 236 7,730 7,997
New York (excluding New York City) 278 312 9,666 10,704
New York City 360 738 24,659 25,515
Pennsylvania 318 413 14,035 14,747
East North Central 470 1,604 42,189 61,260
Illinois 13 577 7,093 19,801
Indiana 47 217 6,526 8,008
Michigan 75 328 9,899 12,145
Ohio 255 421 13,249 15,831
Wisconsin 80 168 5,422 5,475
West North Central 245 689 22,057 27,272
Iowa 33 87 2,514 3,028
Kansas 29 99 2,531 3,400
Minnesota 10 188 5,517 6,006
Missouri 170 260 7,976 10,144
Nebraska - 63 1,598 1,819
North Dakota 2 25 600 946
South Dakota 1 51 1,321 1,929
South Atlantic 882 4,665 100,902 119,254
Delaware 16 54 1,091 1,245
District of Columbia 3 139 4,197 4,511
Florida 392 2,716 32,842 37,000
Georgia - 655 18,669 24,530
Maryland - 301 7,795 9,838
North Carolina 1 536 16,062 21,079
South Carolina 205 301 8,976 9,490
Virginia 262 328 10,741 10,825
West Virginia 3 27 529 736
East South Central 297 821 14,357 30,247
Alabama 204 247 7,000 9,434
Kentucky 62 223 3,700 4,534
Mississippi 31 293 3,657 5,874
Tennessee - 311 - 10,405
West South Central 229 1,696 53,508 64,198
Arkansas 62 131 3,750 4,834
Louisiana 76 281 8,105 10,715
Oklahoma 11 144 3,014 5,725
Texas 80 1,160 38,639 42,924
Mountain 266 823 24,583 28,853
Arizona 18 310 10,044 11,291
Colorado 107 227 4,877 5,976
Idaho 11 25 456 645
Montana 8 28 566 637
Nevada 80 194 4,698 5,099
New Mexico 21 84 2,199 2,869
Utah 21 70 1,623 2,134
Wyoming - 9 120 202
Pacific 1,129 1,926 59,758 74,537
Alaska 19 60 1,625 1,844
California 829 1,509 48,173 59,055
Hawaii - 45 - 1,467
Oregon 96 133 3,331 3,978
Washington 185 275 6,629 8,193
U.S. Territories - 33 37 927
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 33 37 927
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 4 12 16
Total 4,648 12,323 382,531 478,678
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, confirmed and probable cases only are being published to align with the approved CSTE position statement 22-ID-03, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.
Notes:
  • These are weekly cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly in alphabetical order by condition. Cases reported by state health departments to CDC for weekly publication are subject to ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available. Case counts in the tables are presented as published each week. See also Guide to Interpreting Provisional and Finalized NNDSS Data.
  • Weekly tables since 1996 are available on CDC WONDER.
  • Weekly tables since 2014 are available on Data.CDC.gov.
  • Weekly tables for 1952–2017 published in the Morbidity and Mortality Weekly Reports (MMWR) are available at CDC Stacks MMWR, and weekly tables starting in 2018 are available at CDC Stacks NNDSS (once in CDC Stacks NNDSS select "Weekly Tables" in the "Genre" box at the left).
  • Notices, errata, and other notes are available in the Notice To Data Users page.
  • The list of national notifiable infectious diseases and conditions and their national surveillance case definitions are available at https://ndc.services.cdc.gov/. This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved by CSTE for national surveillance.
Suggested Citation:
  • Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System, Weekly Tables of Infectious Disease Data. Atlanta, GA. Office of Public Health Data, Surveillance, and Technology. Available at: https://www.cdc.gov/nndss/data-statistics/index.html.
Acknowledgment:
  • CDC acknowledges the local, state, and territorial health departments that collected the data from a range of case ascertainment sources (e.g., health-care providers, hospitals, laboratories) and reported these data to CDC's National Notifiable Diseases Surveillance System.